Swedish Orphan Biovitrum AB - Company & Market Research Reports

Home /
Companies /
Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company that focuses on developing therapies and treatments for haemophilia, inflammation, genetic and metabolic diseases. Its operations are split into three core areas: Core Products, Partner Products and ReFacto Manufacturing. The organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. However, Europe accounts for up to 54 per cent of its sales. Sobi is headquartered in Stockholm, Sweden.

REFINE BY

KEYWORD

Gout Therapeutics Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4975EUR$5,000USD£4,140GBP

Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, Type of Biologics, Route of Administration, Type of Therapy, Key Geographical Regions, Leading Drug Developers and Sales Forecast

 Report
May 2024
240 Pages
Global

From

€4775EUR$4,799USD£3,973GBP

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

 Report
February 2022
84 Pages
Global

From

€1292EUR$1,299USD£1,075GBP

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035

 Report
October 2022
338 Pages
Europe, Global, Asia Pacific Europe, Global, Asia Pacific

From

€4775EUR$4,799USD£3,973GBP

Inflammatory Bowel Disease Treatment Market by Type, Drug Class, Route of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
183 Pages
Global

From

€3919EUR$3,939USD£3,261GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Lysosomal Storage Diseases Market by Disease Type, Type of Therapy, End User - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3919EUR$3,939USD£3,261GBP

Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental Principle, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Leading Players and Sales Forecast

 Report
November 2024
997 Pages
Global

From

€4775EUR$4,799USD£3,973GBP

Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
432 Pages
Global

From

€2487EUR$2,500USD£2,070GBP

Hemophilia Drugs - Global Strategic Business Report

 Report
February 2025
182 Pages
Global

From

€4925EUR$4,950USD£4,098GBP

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
March 2023
394 Pages
Global

From

€2487EUR$2,500USD£2,070GBP

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

 Report
November 2024
716 Pages
Global

From

€4775EUR$4,799USD£3,973GBP

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

 Report
July 2023
3600 Pages
United States

From

€8059EUR$8,100USD£6,706GBP

€8954EUR$9,000USD£7,451GBP

Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
October 2022
182 Pages
Global

From

€2487EUR$2,500USD£2,070GBP

Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027

 Report
April 2022
326 Pages
Global

From

€3731EUR$3,750USD£3,105GBP

Paroxysmal Nocturnal Hemoglobinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 Report
May 2024
129 Pages
Global

From

€6466EUR$6,499USD£5,381GBP

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
160 Pages
Global

From

€1990EUR$2,000USD£1,656GBP

Fc Fusion Therapeutics Market by Target Indications, Type of Fusion Molecule, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
150 Pages
Global

From

€4775EUR$4,799USD£3,973GBP

Cold Agglutinin Disease Market Insight, Epidemiology And Market Forecast - 2032

 Report
April 2023
145 Pages
Global

From

€7462EUR$7,500USD£6,209GBP

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
77 Pages
Global

From

€1990EUR$2,000USD£1,656GBP

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

 Report
February 2020
360 Pages
Global

From

€4874EUR$4,899USD£4,056GBP

67 Results (Page 1 of 4)
- 1
- 2
- 3

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.